Today more than ever, millions of lives depend on the availability, accuracy, and integrity of healthcare networks as they treat patients, develop vaccines, and research medical solutions. The COVID-19 global pandemic is shining a spotlight on the critical role that healthcare research plays in national security, creating a unique opportunity to discuss the impact vulnerabilities have on this vital ecosystem. In the months since the outbreak of the virus, Chinese cyberespionage and advanced persistent threat (APT) attacks have spiked as adversaries targeted HHS and the wider medical sector in a broad campaign tailored to steal vital healthcare research. Around the world, nation-state and criminal adversaries are aggressively exploiting vulnerabilities in healthcare research environments to steal intellectual property (IP) and disrupt medical device performance. If leaders continue to eschew security and ignore the reality that their R&D is being targeted, organizations will face insurmountable financial harm, our economy will suffer, our national security will degrade, and patients’ lives will be lost.
Read the Full Whitepaper